GlassScriptPhysician profile
Bradley Dowden
NPI 1164432415
$876.58
in general payments reported to CMS, 2019-2025
21 companies · $138 in 2025
The $138 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $103 · 2020: $41.19 · 2021: $89.97 · 2022: $176 · 2023: $158 · 2024: $170 · 2025: $138.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $466.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $465.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $176.64 | 2021-2024 | Vraylar, Ubrelvy |
| Astrazeneca Pharmaceuticals LP | $97.94 | 2022-2025 | Airsupra, Breztri |
| Novo Nordisk INC | $91.43 | 2019-2024 | Wegovy, Rybelsus, Ozempic |
| Lilly USA, LLC | $75.23 | 2022-2025 | Mounjaro, Zepbound, Kisunla |
| Pfizer INC. | $56.86 | 2022-2024 | |
| Glaxosmithkline, LLC. | $53.48 | 2021-2023 | Shingrix, Arexvy |
| Abbott Laboratories | $46.14 | 2021-2025 | Freestyle Libre 3 |
| Boehringer Ingelheim Pharmaceuticals, INC. | $37.47 | 2024 | Ofev |
| Otsuka America Pharmaceutical, INC. | $33.47 | 2024 | Rexulti |
| Allergan, INC. | $24.88 | 2019 | |
| Ardelyx, INC. | $21.15 | 2025 | Ibsrela |
| Lundbeck LLC | $19.60 | 2025 | Rexulti |
| Kowa Pharmaceuticals America, INC. | $18.13 | 2025 | Zoryve |
| Sanofi Pasteur INC. | $17.94 | 2023 | |
| Exact Sciences Corporation | $17.73 | 2023 | Cologuard Collection Kit |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $16.75 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $15.30 | 2020 | |
| Amgen INC. | $15.23 | 2022 | |
| Janssen Pharmaceuticals, INC | $15.20 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.57 | 2020 | |
| Seqirus USA INC | $11.44 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bradley Dowden listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.